Breast cancer vaccine in three years?
In fact, an international team, led by the University of Georgia, has already developed the vaccine, but the scientists are now beginning tests on human cells before it's launched in the market, 'The Sun' reported।
Added team member Prof Sandra Gendler of the Mayo Clinic in Arizona: "This is the first time a vaccine has been developed that trains the immune system to distinguish and kill cancer cells based on their different sugar structures."
Experts have welcomed the findings। "This exciting new approach could lead to treatments for breast cancer patients who have few options," Dr Caitlin Palframan of Breakthrough Breast Cancer in the UK was quoted by the newspaper as saying। However, she said trials on patients are needed।